Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Forethought Consulting

With exceptional honest advice and counsel to enable the development of your public affairs strategies. Projects are neither too small nor too large. We can provide the necessary expertise from monitoring and analysis of a situation through to the development and implementation of a public affairs programme to support your business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Health policy and government affairs, Market access, Market research

Company Details

Forethought Consulting
11 Maybury Mews, London, N6 5YT, United Kingdom
+44 (0)20 8340 3258
Contact Forethought Consulting
Website

 Latest Content from PMHub 

Breakthrough Alzheimer’s Therapies Drive Early Detection Rates While Exposing Deep Treatment Disparities

Press Releases | September 22, 2025 | Medscape Education

Analysis from Komodo Health and Medscape Education shows cognitive screening up 10% and biomarker testing up 23%, yet significant disparities persist in detection for women and treatment access for Black...

CMI Media Group and Compas Earn 2025 Great Place To Work Certification

Press Releases | September 19, 2025 | CMI Media Group

PHILADELPHIA, PA – Strategic media healthcare agencies CMI Media Group & Compas, a WPP company (NYSE: WPP), are proud to be Certified™ by Great Place To Work® for the third year in...

solli – CMI’s International Man of Media

Press Releases | September 19, 2025 | CMI Media Group

Matt Durham, VP, Global, anticipated pharma’s global media boom. Now he’s leading CMI Media Group’s push to broaden its market coverage. This new profile article focusing on Global VP Matt...

PharmiWeb – Why Pharmaceutical Brands Must Act On Digital Trends Now

Press Releases | September 19, 2025 | CMI Media Group

The ASCO Conference has a global impact; a new PharmiWeb byline by Calum Griffin, Senior Global Engagement Planner inspired by the conference shares that the pharma marketing landscape has radically...

Genetic Digital Wins Silver at PM Society Digital Awards for Epilepsy Meds Clinical Support App

Press Releases | September 18, 2025 | Genetic Digital

Genetic Digital wins Silver at the PM Society Digital Awards for Epilepsy Meds, a clinical support app developed with Desitin and ChangeMed to aid patient-specific prescribing in epilepsy care.

AstraZeneca and Merck decision to disinvest in the UK is a ‘tragedy’ for British research and innovation

Press Releases | September 17, 2025 | Innovative Trials

Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK

Lucid Strategy Consulting: Empowering Next-Generation Solutions for Life Sciences

Press Releases | September 16, 2025 | Lucid Group Communications Limited

Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid...

Streamlining European expansion for cell and gene therapies

White Papers and Resources | September 16, 2025 | Uniphar

Tom Smith, Strategic Director, Cell and Gene Therapies, Uniphar, discusses the essential elements biotechs need for commercial success in Europe’s unique market when developing cell and gene therapies (CGTs). Europe...

Current CGT landscape and future outlook  

White Papers and Resources | September 16, 2025 | Uniphar

What makes CGT unique  Cell and gene therapy (CGT) is a unique treatment that uses cells and genetic material to treat and cure diseases. Personalized to the patient, CGT’s offer...

Building for Success: Aligning Preclinical and Phase 1 Strategy with Commercial Goals 

White Papers and Resources | September 16, 2025 | Uniphar

This article concludes our three-part series on preparing cell and gene therapies (CGTs) for successful launch and long-term viability. The first article explored the unique scientific and logistical challenges of...